| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Gene |
| Molecule Category: | UNKNOWN |
| ATC: | L01XX70 |
| UNII: | U2I8T43Y7R |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | B-lymphocyte antigen CD19 binding agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Follicular | 4 | D008224 | ClinicalTrials |
| Systemic Inflammatory Response Syndrome | 2 | D018746 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
| Hematologic Neoplasms | 2 | D019337 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 1 | D008228 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3989989 |
| FDA SRS | U2I8T43Y7R |
CONTENTS